SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850261-19-000036
Filing Date
2019-11-12
Accepted
2019-11-08 20:46:50
Documents
94
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-20190930.htm   iXBRL 10-Q 2526483
2 EX-2.2 exhibit22.htm EX-2.2 17848
3 EXHIBIT 10.5 exhibit105.htm EX-10..5 196523
4 EX-31.1 exhibit311093019.htm EX-31.1 10220
5 EX-31.2 exhibit312093019.htm EX-31.2 9685
6 EX-32.1 exhibit321093019.htm EX-32.1 16115
  Complete submission text file 0000850261-19-000036.txt   11677371

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20190930.xsd EX-101.SCH 79922
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20190930_cal.xml EX-101.CAL 116776
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20190930_def.xml EX-101.DEF 538375
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20190930_lab.xml EX-101.LAB 896123
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20190930_pre.xml EX-101.PRE 651593
31 EXTRACTED XBRL INSTANCE DOCUMENT srne-20190930_htm.xml XML 2061548
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 191205440
SIC: 8731 Services-Commercial Physical & Biological Research